Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast Cancer
Clinical trial NCT06098599 · COMPLETED
Trial details
- NCT number
- NCT06098599
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2023-02-09
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.